ID   LEPR_RAT                Reviewed;        1162 AA.
AC   Q62959; O35772; O35773; O54805; P70493; P70494; P70495; P97589; Q62960;
AC   Q63007; Q63385; Q63386; Q9ERI4;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 167.
DE   RecName: Full=Leptin receptor;
DE            Short=LEP-R;
DE   AltName: Full=OB receptor;
DE            Short=OB-R;
DE   AltName: CD_antigen=CD295;
DE   Flags: Precursor;
GN   Name=Lepr; Synonyms=Fa, Obr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND VARIANT FA PRO-269.
RC   STRAIN=Zucker; TISSUE=Hypothalamus;
RX   PubMed=8673096; DOI=10.1038/ng0596-18;
RA   Phillips M.S., Liu Q., Hammond H.A., Dugan V., Hey P.J., Caskey C.T.,
RA   Hess J.F.;
RT   "Leptin receptor missense mutation in the fatty Zucker rat.";
RL   Nat. Genet. 13:18-19(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND VARIANT FA PRO-269.
RC   STRAIN=Sprague-Dawley, and Zucker fatty; TISSUE=Brain;
RX   PubMed=8702432; DOI=10.1006/bbrc.1996.1070;
RA   Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K.;
RT   "Substitution at codon 269 (glutamine --> proline) of the leptin receptor
RT   (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat.";
RL   Biochem. Biophys. Res. Commun. 224:597-604(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND E), AND VARIANT FA PRO-269.
RC   STRAIN=Sprague-Dawley, and Zucker fatty;
RX   PubMed=8769097; DOI=10.1006/bbrc.1996.1133;
RA   Takaya K., Ogawa Y., Isse N., Okazaki T., Satoh N., Masuzaki H., Mori K.,
RA   Tamura N., Hosoda K., Nakao K.;
RT   "Molecular cloning of rat leptin receptor isoform complementary DNAs
RT   -- identification of a missense mutation in Zucker fatty (fa/fa) rats.";
RL   Biochem. Biophys. Res. Commun. 225:75-83(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RA   Karlsson C., Lindell K., Robinson I.C.A.F., Carlsson L.M.S., Carlsson B.;
RT   "Cloning of the rat leptin receptor.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND VARIANT FA PRO-269.
RC   STRAIN=Sprague-Dawley, and Zucker fatty;
RX   PubMed=8630068; DOI=10.1006/bbrc.1996.0691;
RA   Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K.;
RT   "Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker
RT   fatty (fa/fa) rat.";
RL   Biochem. Biophys. Res. Commun. 222:19-26(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   STRAIN=Sprague-Dawley; TISSUE=Spleen;
RA   Park J.H., Ju S.K., Na S.Y., You K.H., Kim K.L.;
RT   "Molecular cloning, sequencing, and recombinant expression of the long form
RT   of the rat leptin receptor isolated from whole spleen RNA.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8772180; DOI=10.1016/0014-5793(96)00790-9;
RA   Wang M.-Y., Zhou Y.T., Newgard C.B., Unger R.H.;
RT   "A novel leptin receptor isoform in rat.";
RL   FEBS Lett. 392:87-90(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-123.
RA   Morishita T., Hidaka T., Kuzuyama T., Noguchi T.;
RT   "Analysis of rat leptin receptor gene.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 557-802 AND 843-892 (ISOFORMS C AND E).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9268737; DOI=10.1006/bbrc.1997.7159;
RA   Chien E.K., Hara M., Rouard M., Yano H., Phillippe M., Polonsky K.S.,
RA   Bell G.I.;
RT   "Increase in serum leptin and uterine leptin receptor messenger RNA levels
RT   during pregnancy in rats.";
RL   Biochem. Biophys. Res. Commun. 237:476-480(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 694-878.
RC   STRAIN=Sprague-Dawley; TISSUE=Pancreas;
RA   Ma Z.;
RT   "Identification of a leptin receptor in islet.";
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 821-894 (ISOFORM A).
RC   STRAIN=Wistar Munich; TISSUE=Kidney;
RA   Totsune K., Takahashi K., Mackenzie H.S., Murakami O., Arihara Z., Sone M.,
RA   Satoh F., Mouri T., Brenner B.M., Ito S.;
RT   "Leptin receptor gene expression in rat kidney.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   FUNCTION (ISOFORM A).
RX   PubMed=10698121; DOI=10.1016/s0196-9781(99)00156-4;
RA   Kastin A.J., Pan W., Maness L.M., Koletsky R.J., Ernsberger P.;
RT   "Decreased transport of leptin across the blood-brain barrier in rats
RT   lacking the short form of the leptin receptor.";
RL   Peptides 20:1449-1453(1999).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=11861497; DOI=10.1210/endo.143.3.8669;
RA   Hileman S.M., Pierroz D.D., Masuzaki H., Bjoerbaek C., El-Haschimi K.,
RA   Banks W.A., Flier J.S.;
RT   "Characterization of short isoforms of the leptin receptor in rat cerebral
RT   microvessels and of brain uptake of leptin in mouse models of obesity.";
RL   Endocrinology 143:775-783(2002).
RN   [14]
RP   REVIEW ON FUNCTION, AND SUBUNIT.
RX   PubMed=25232147; DOI=10.1530/joe-14-0404;
RA   Allison M.B., Myers M.G. Jr.;
RT   "20 years of leptin: connecting leptin signaling to biological function.";
RL   J. Endocrinol. 223:T25-T35(2014).
RN   [15]
RP   VARIANT FA PRO-269.
RX   PubMed=8690163; DOI=10.2337/diab.45.8.1141;
RA   Chua S.C. Jr., White D.W., Wu-Peng X.S., Liu S.M., Okada N., Kershaw E.E.,
RA   Chung W.K., Power-Kehoe L., Chua M., Tartaglia L.A., Leibel R.L.;
RT   "Phenotype of fatty due to Gln269Pro mutation in the leptin receptor
RT   (Lepr).";
RL   Diabetes 45:1141-1143(1996).
CC   -!- FUNCTION: Receptor for hormone LEP/leptin (Probable). On ligand
CC       binding, mediates LEP central and peripheral effects through the
CC       activation of different signaling pathways such as JAK2/STAT3 and MAPK
CC       cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating
CC       factor that induces a decrease in food intake and an increase in energy
CC       consumption by inducing anorexinogenic factors and suppressing
CC       orexigenic neuropeptides, also regulates bone mass and secretion of
CC       hypothalamo-pituitary-adrenal hormones (PubMed:8690163). In the
CC       periphery, increases basal metabolism, influences reproductive
CC       function, regulates pancreatic beta-cell function and insulin
CC       secretion, is pro-angiogenic and affects innate and adaptive immunity
CC       (By similarity). Control of energy homeostasis and melanocortin
CC       production (stimulation of POMC and full repression of AgRP
CC       transcription) is mediated by STAT3 signaling, whereas distinct signals
CC       regulate NPY and the control of fertility, growth and glucose
CC       homeostasis. Involved in the regulation of counter-regulatory response
CC       to hypoglycemia by inhibiting neurons of the parabrachial nucleus. Has
CC       a specific effect on T lymphocyte responses, differentially regulating
CC       the proliferation of naive and memory T-cells. Leptin increases Th1 and
CC       suppresses Th2 cytokine production (By similarity).
CC       {ECO:0000250|UniProtKB:P48356, ECO:0000250|UniProtKB:P48357,
CC       ECO:0000269|PubMed:8690163, ECO:0000305|PubMed:25232147}.
CC   -!- FUNCTION: [Isoform A]: May transport LEP across the blood-brain
CC       barrier. Binds LEP and mediates LEP endocytosis (PubMed:10698121). Does
CC       not induce phosphorylation of and activate STAT3 (By similarity).
CC       {ECO:0000250|UniProtKB:P48356, ECO:0000269|PubMed:10698121}.
CC   -!- FUNCTION: [Isoform E]: Antagonizes Isoform A and isoform B-mediated LEP
CC       binding and endocytosis. {ECO:0000250|UniProtKB:P48356}.
CC   -!- SUBUNIT: Present as a mixture of monomers and dimers (Probable). The
CC       phosphorylated receptor binds a number of SH2 domain-containing
CC       proteins such as JAK2, STAT3, PTPN11, and SOCS3 (By similarity).
CC       Interaction with SOCS3 inhibits JAK/STAT signaling and MAPK cascade (By
CC       similarity). {ECO:0000250|UniProtKB:P48356,
CC       ECO:0000250|UniProtKB:P48357, ECO:0000305|PubMed:25232147}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P48357};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P48357}.
CC       Basolateral cell membrane {ECO:0000250|UniProtKB:P48357}.
CC   -!- SUBCELLULAR LOCATION: [Isoform E]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=B;
CC         IsoId=Q62959-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q62959-2; Sequence=VSP_001705, VSP_001706;
CC       Name=C;
CC         IsoId=Q62959-3; Sequence=VSP_001707, VSP_001708;
CC       Name=D;
CC         IsoId=Q62959-6; Sequence=Not described;
CC       Name=E;
CC         IsoId=Q62959-4; Sequence=VSP_001709, VSP_001710;
CC       Name=F;
CC         IsoId=Q62959-5; Sequence=VSP_001711, VSP_001712;
CC   -!- TISSUE SPECIFICITY: Isoform B is expressed in kidney, liver, lung,
CC       ovary, spleen and uterus. Increased level in uterus during gestation
CC       (PubMed:8772180). Isoform A and isoform C are predominantly expressed
CC       in cerebral microvessels and choroid plexus, with lower levels in
CC       cortex, cerebellum and hypothalamus but also liver and lung
CC       (PubMed:11861497). Isoform F is expressed at high levels in brain,
CC       liver and spleen and less in stomach, kidney, thymus, heart, lung and
CC       hypothalamus (PubMed:11861497, PubMed:8772180).
CC       {ECO:0000269|PubMed:11861497, ECO:0000269|PubMed:8772180}.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- PTM: On ligand binding, phosphorylated on two conserved C-terminal
CC       tyrosine residues (isoform B only) by JAK2. Tyr-985 is required for
CC       complete binding and activation of PTPN11, ERK/FOS activation,for
CC       interaction with SOCS3 and SOCS3 mediated inhibition of leptin
CC       signaling. Phosphorylation on Tyr-1138 is required for STAT3
CC       binding/activation. Phosphorylation of Tyr-1077 has a more accessory
CC       role. {ECO:0000250|UniProtKB:P48356}.
CC   -!- DISEASE: Note=The fatty (Fa) mutation produces profound obesity of
CC       early onset caused by hyperphagia, defective non-shivering
CC       thermogenesis, and preferential deposition of energy into adipose
CC       tissue.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U52966; AAC52587.1; -; mRNA.
DR   EMBL; D84550; BAA12697.1; -; mRNA.
DR   EMBL; D84551; BAA12698.1; -; mRNA.
DR   EMBL; D85557; BAA12830.1; -; mRNA.
DR   EMBL; D85558; BAA12831.1; -; mRNA.
DR   EMBL; D85559; BAA12832.1; -; mRNA.
DR   EMBL; U60151; AAB06616.1; -; mRNA.
DR   EMBL; D84125; BAA12230.1; -; mRNA.
DR   EMBL; D84126; BAA12231.1; -; mRNA.
DR   EMBL; AF287268; AAF89300.1; -; mRNA.
DR   EMBL; U53144; AAB03088.1; -; mRNA.
DR   EMBL; AB011006; BAA24899.1; -; Genomic_DNA.
DR   EMBL; AF007818; AAB63201.1; -; mRNA.
DR   EMBL; AF007819; AAB63202.1; -; mRNA.
DR   EMBL; U67207; AAB40654.1; -; mRNA.
DR   EMBL; AF304191; AAG22823.1; -; mRNA.
DR   PIR; JC4895; PC4184.
DR   PIR; S74225; S74225.
DR   RefSeq; NP_036728.1; NM_012596.1.
DR   AlphaFoldDB; Q62959; -.
DR   SMR; Q62959; -.
DR   BioGRID; 246689; 1.
DR   STRING; 10116.ENSRNOP00000045398; -.
DR   GlyCosmos; Q62959; 17 sites, No reported glycans.
DR   GlyGen; Q62959; 17 sites.
DR   iPTMnet; Q62959; -.
DR   PhosphoSitePlus; Q62959; -.
DR   PaxDb; 10116-ENSRNOP00000046647; -.
DR   GeneID; 24536; -.
DR   KEGG; rno:24536; -.
DR   AGR; RGD:3001; -.
DR   CTD; 3953; -.
DR   RGD; 3001; Lepr.
DR   eggNOG; ENOG502RK5B; Eukaryota.
DR   InParanoid; Q62959; -.
DR   OrthoDB; 5344962at2759; -.
DR   PhylomeDB; Q62959; -.
DR   PRO; PR:Q62959; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0038021; F:leptin receptor activity; ISS:UniProtKB.
DR   GO; GO:0017046; F:peptide hormone binding; IDA:RGD.
DR   GO; GO:0016500; F:protein-hormone receptor activity; IDA:RGD.
DR   GO; GO:0001525; P:angiogenesis; IMP:RGD.
DR   GO; GO:0098868; P:bone growth; ISS:UniProtKB.
DR   GO; GO:0071311; P:cellular response to acetate; IEP:RGD.
DR   GO; GO:1903545; P:cellular response to butyrate; IEP:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0097009; P:energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; NAS:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.
DR   GO; GO:0006094; P:gluconeogenesis; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; ISO:RGD.
DR   GO; GO:0033210; P:leptin-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:1903999; P:negative regulation of eating behavior; IMP:RGD.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISO:RGD.
DR   GO; GO:1904060; P:negative regulation of locomotor rhythm; IMP:RGD.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEP:RGD.
DR   GO; GO:0006909; P:phagocytosis; ISS:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IDA:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0046850; P:regulation of bone remodeling; ISS:UniProtKB.
DR   GO; GO:0060259; P:regulation of feeding behavior; ISS:UniProtKB.
DR   GO; GO:0051049; P:regulation of transport; ISO:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0044321; P:response to leptin; IEP:RGD.
DR   GO; GO:0033993; P:response to lipid; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0019953; P:sexual reproduction; ISS:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 7.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR010457; IgC2-like_lig-bd.
DR   InterPro; IPR041182; LEP-R_IGD.
DR   InterPro; IPR050379; Type-I_Cytokine_Rcpt.
DR   PANTHER; PTHR23036; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR23036:SF151; MYOTACTIN FORM B; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF06328; Lep_receptor_Ig; 1.
DR   Pfam; PF18589; ObR_Ig; 2.
DR   SMART; SM00060; FN3; 4.
DR   SUPFAM; SSF49265; Fibronectin type III; 4.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disease variant; Disulfide bond;
KW   Glycoprotein; Membrane; Obesity; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1162
FT                   /note="Leptin receptor"
FT                   /id="PRO_0000010908"
FT   TOPO_DOM        22..839
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        840..860
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        861..1162
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          238..331
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          537..632
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          637..729
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          738..831
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          465..482
FT                   /note="Leptin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   REGION          891..896
FT                   /note="Required for JAK2 activation"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   REGION          896..904
FT                   /note="Required for STAT3 phosphorylation"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOTIF           620..624
FT                   /note="WSXWS motif"
FT   MOTIF           869..877
FT                   /note="Box 1 motif"
FT   MOD_RES         880
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   MOD_RES         985
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOD_RES         1077
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOD_RES         1138
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        356
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        431
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        514
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        622
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        657
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        668
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        686
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        695
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        698
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        726
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        37..90
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        89..99
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        131..142
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        186..195
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        188..193
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        350..410
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        411..416
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        434..445
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        471..526
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        486..496
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   VAR_SEQ         797..805
FT                   /note="DNFIPIEKY -> GMCTVLLLN (in isoform E)"
FT                   /evidence="ECO:0000303|PubMed:8769097,
FT                   ECO:0000303|PubMed:9268737"
FT                   /id="VSP_001709"
FT   VAR_SEQ         806..1162
FT                   /note="Missing (in isoform E)"
FT                   /evidence="ECO:0000303|PubMed:8769097,
FT                   ECO:0000303|PubMed:9268737"
FT                   /id="VSP_001710"
FT   VAR_SEQ         890..895
FT                   /note="PETFEH -> IMPGRN (in isoform F)"
FT                   /evidence="ECO:0000303|PubMed:8772180"
FT                   /id="VSP_001711"
FT   VAR_SEQ         890..894
FT                   /note="PETFE -> RADTL (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:8630068,
FT                   ECO:0000303|PubMed:8769097, ECO:0000303|Ref.11"
FT                   /id="VSP_001705"
FT   VAR_SEQ         890..892
FT                   /note="PET -> VTV (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:9268737"
FT                   /id="VSP_001707"
FT   VAR_SEQ         893..1162
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:9268737"
FT                   /id="VSP_001708"
FT   VAR_SEQ         895..1162
FT                   /note="Missing (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:8630068,
FT                   ECO:0000303|PubMed:8769097, ECO:0000303|Ref.11"
FT                   /id="VSP_001706"
FT   VAR_SEQ         896..1162
FT                   /note="Missing (in isoform F)"
FT                   /evidence="ECO:0000303|PubMed:8772180"
FT                   /id="VSP_001712"
FT   VARIANT         269
FT                   /note="Q -> P (in FA)"
FT                   /evidence="ECO:0000269|PubMed:8630068,
FT                   ECO:0000269|PubMed:8673096, ECO:0000269|PubMed:8690163,
FT                   ECO:0000269|PubMed:8702432, ECO:0000269|PubMed:8769097"
FT   CONFLICT        2
FT                   /note="T -> M (in Ref. 4; AAB06616)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12
FT                   /note="H -> P (in Ref. 8; BAA24899)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        34
FT                   /note="K -> R (in Ref. 8; BAA24899)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415..417
FT                   /note="ACH -> QCQ (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        422
FT                   /note="E -> D (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        493
FT                   /note="F -> L (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        498
FT                   /note="F -> S (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        612
FT                   /note="R -> Q (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        690
FT                   /note="S -> T (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        703..704
FT                   /note="WA -> SG (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        714
FT                   /note="A -> D (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        738..739
FT                   /note="AV -> GW (in Ref. 7; AAB03088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        751..752
FT                   /note="CV -> SL (in Ref. 10; AAB40654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        766
FT                   /note="L -> S (in Ref. 9; AAB63202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        785
FT                   /note="R -> K (in Ref. 9; AAB63202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        794
FT                   /note="Y -> N (in Ref. 9; AAB63202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        846
FT                   /note="I -> V (in Ref. 9; AAB63201)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1162 AA;  130833 MW;  BA7AC2CA2D2E62AF CRC64;
     MTCQKFYVVL LHWEFLYVIT ALNLAYPTSP WRFKLFCAPP STTDDSFLSP AGVPNNTSSL
     KGASEALVEA KFNSTGIYVS ELSKTIFHCC FGNEQGQNCS ALTGNTEGKT LASVVKPLVF
     RQLGVNWDIE CWMKGDLTLF ICHMEPLLKN PFKNYDSKVH LLYDLPEVID DLPLPPLKDS
     FQTVQCNCSV RECECHVPVP RAKVNYALLM YLEITSAGVS FQSPLMSLQP MLVVKPDPPL
     GLRMEVTDDG NLKISWDSQT KAPFPLQYQV KYLENSTIVR EAAEIVSDTS LLVDSVLPGS
     SYEVQVRSKR LDGSGVWSDW SLPQLFTTQD VMYFPPKILT SVGSNASFCC IYKNENQTIS
     SKQIVWWMNL AEKIPETQYN TVSDHISKVT FSNLKATRPR GKFTYDAVYC CNEQACHHRY
     AELYVIDVNI NISCETDGYL TKMTCRWSPS TIQSLVGSTV QLRYHRRSLY CPDNPSIRPT
     SELKNCVLQT DGFYECVFQP IFLLSGYTMW IRINHSLGSL DSPPTCVLPD SVVKPLPPSN
     VKAEITINTG LLKVSWEKPV FPENNLQFQI RYGLNGKEIQ WKTHEVFDAK SKSASLPVSD
     LCAVYVVQVR CRRLDGLGYW SNWSSPAYTL VMDVKVPMRG PEFWRIMDGD ITKKERNVTL
     LWKPLMKNDS LCSVRRYVVK HRTAHNGTWS QDVGNQTNLT FLWAESAHTV TVLAINSIGA
     SLVNFNLTFS WPMSKVNAVQ SLSAYPLSSS CVILSWTLSP NDYSLLYLVI EWKNLNDDDG
     MKWLRIPSNV NKYYIHDNFI PIEKYQFSLY PVFMEGVGKP KIINGFTKDD IAKQQNDAGL
     YVIVPIIISS CVLLLGTLLI SHQRMKKLFW DDVPNPKNCS WAQGLNFQKP ETFEHLFTKH
     AESVIFGPLL LEPEPVSEEI SVDTAWKNKD EMVPAAMVSL LLTTPDSTRG SICISDQCNS
     ANFSGAQSTQ GTCEDECQSQ PSVKYATLVS NVKTVETDEE QGAIHSSVSQ CIARKHSPLR
     QSFSSNSWEI EAQAFFLLSD HPPNVISPQL SFSGLDELLE LEGNFPEENH GEKSVYYLGV
     SSGNKRENDM LLTDEAGVLC PFPAHCLFSD IRILQESCSH FVENNLNLGT SGKNFVPYMP
     QFQSCSTHSH KIIENKMCDL TV
//
